Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya, GECO-Kenya

Kenya, , 2021 - 2023
Health and Well-Being (HaW)

Gershim Asiki,MD,Phd

CSV JSON

(iii) Duration of use (q3p8a3)

Data file: GECO_FinalData1

Overview

vald 483

invd 17

Interval discrete

Decimal 0

Range 1 - 96

Questions and instructions

Literal question

Think about the 3 months before [pre-COVID]. i.e between Jan and March 2020. Please indicate medication's:
Fikiria kuhusu miezi 3 kabla ya [COVID], kisha ueleze;
(c) Duration (e.g. used for only one month; for three months)
Muda (k.m. kutumika kwa mwezi mmoja tu; kwa miezi mitatu)

Categories

Value	Category	Cases
1	(a) one month only	242	50.1%
2	(b) two months	19	3.9%
3	(c) three months	148	30.6%
96	(96) Other specify	74	15.3%
Sysmiss		17

Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.

Question pretext

Medications
[PRE-COVID] period = before March 2020

Question post text

N/A

Interviewer instructions

N/A

Description

Text

The question was asked to patients with type 2 diabetes to indicate the duration they used insulin during the three months before the COVID-19 pandemic, specifically between January and March 2020.

Universe

Patients with type 2 diabetes

others

Notes

"(iii) Duration of use"